Skip to main content
Columbia University in the City of New York
Columbia University
Lab to Market Accelerator Network logoLab to Market Accelerator Network

Main navigation expanded

  • About L2M
  • Accelerators
  • Calendar
  • Startups / Teams
  • L2M Knowledge Bank
  • External Resources
  • Get Involved
  • All Accelerators
  • Accelerating Cancer Therapeutics (ACT)
  • Beiersdorf & Columbia Skin Science Collaboration
  • Biomedical Engineering Technology Accelerator (BiomedX)
  • Carbontech Development Initiative (CDI)
  • Columbia | Corning Advanced Materials Prize
  • Columbia | IBM Launch Accelerator
  • Columbia-NYU-Takeda Alliance
  • Columbia-SDP Oncology Research Alliance
  • Cyber NYC Inventors to Founders
  • Department of Orthopedic Surgery Innovation Fund
  • Department of Surgery Innovation Fund
  • Hudson Heights Innovations
  • Materialize New York
  • 'Math Meets Bio’ Columbia-AlleyCorp Collaboration
  • NSF Engineering Research Center for Smart Streetscapes (CS3) VALIDATE Accelerator
  • NYC Media Lab Combine
  • New York State Biodefense Commercialization Fund
  • Point-of-Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
  • PowerBridgeNY
  • RTW Charitable Foundation Accelerator
  • Translational Therapeutics Accelerator (TRx)
Lab to Market Accelerator Network logo Lab to Market Accelerator Network

You are here:

  1. Home
  2. Documents
  3. NYS Biodefense Commercialization Fund Code of Conduct

NYS Biodefense Commercialization Fund Code of Conduct

November 01, 2022
Biodefense-Commercialization-Fund-Code-of-Conduct-Updated-100421.pdf
Columbia Lab-to-Market Accelerator Network3280 Broadway 2nd Floor · New York, NY 10027

Phone

212-854-8444

Contact Us

[email protected]
Columbia University Columbia University Logo
©2026 Columbia University Accessibility Nondiscrimination Careers Built using Columbia Sites